Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 9.03 USD 4.27% Market Closed
Market Cap: 475.2m USD
Have any thoughts about
Zevra Therapeutics Inc?
Write Note

Zevra Therapeutics Inc
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zevra Therapeutics Inc
PP&E Gross Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zevra Therapeutics Inc
NASDAQ:ZVRA
PP&E Gross
$1.6m
CAGR 3-Years
-10%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
PP&E Gross
$20.5B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
PP&E Gross
$8.3B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
7%
Pfizer Inc
NYSE:PFE
PP&E Gross
$19B
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
PP&E Gross
$23.4B
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
PP&E Gross
$16.2B
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
7%

See Also

What is Zevra Therapeutics Inc's PP&E Gross?
PP&E Gross
1.6m USD

Based on the financial report for Jun 30, 2024, Zevra Therapeutics Inc's PP&E Gross amounts to 1.6m USD.

What is Zevra Therapeutics Inc's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
-14%

Over the last year, the PP&E Gross growth was 6%. The average annual PP&E Gross growth rates for Zevra Therapeutics Inc have been -10% over the past three years , -14% over the past five years .

Back to Top